The management of glaucoma with drugs is mostly via the topical route, although these treatments have poor ocular bioavailability. Other problems limiting their therapeutic effect include pre-corneal clearance, corneal and ocular surface barriers, and the need for a long-term treatment regimen. Nanoparticle-mediated dr...
Matteo Capobianco, Marco Zeppieri, M. L. Salvetat et al.· Pharmaceuticals· 0 citations
The development and validation of robust OCT-based biomarkers have the potential to enable earlier diagnosis, improved disease monitoring, and personalised treatment strategies, and future research that integrates quantitative imaging, computational analysis, and longitudinal clinical data will be essential to fully re...
Lan-Xing Fu, Y. Luo, Nick Kopsachilis et al.· Diseases· 0 citations
The capacity of TSI to deliver lutein inside the retina, overcoming physiological barriers that may limit the efficacy of lutein oral administration is highlighted, overcoming physiological barriers that may limit the efficacy of lutein oral administration.
M. L. Salvetat, Francesco Pellegrini, Marco Zeppieri et al.· Diseases· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
